Both in Pharmaceuticals
Verrica Pharmaceuticals vs Xilio Therapeutics
Over the past year VRCA returned −7.6% and XLO returned −27.1%; their daily moves had a correlation of 0.00.
VRCA −7.6% XLO −27.1%Growth of $1, one year, split-adjusted
| Metric | VRCA | XLO |
|---|---|---|
| Price | $3.29 | $8.68 |
| Market cap | $56.5M | $57.1M |
| Today | +2.49% | +8.64% |
| 1 month | −23.7% | −4.7% |
| 6 months | −54.1% | +12.6% |
| Year to date | −60.4% | −3.2% |
| 1 year | −8.9% | −22.2% |
| Revenue growth (YoY) | −53.8% | +131.2% |
| Gross margin | 85.0% | 100.0% |
| Net margin | −224.4% | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | 0.9× |
| Net cash | $9.8M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 38.3% |
| Short % of float | 2.5% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).